CRC patients were divided into two groups according to their median expression of ABHD11-AS1, and Kaplan–Meier analysis indicated that the up-regulation of ABHD11-AS1 was associated with significantly shorter overall survival (Figure 1D, P = 0.027). Here, ABHD11 is linked to colorectal carcinoma.